Rhenman & Partners Asset Management Ab Laboratory Corp Of America Holdings Transaction History

Rhenman & Partners Asset Management Ab

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $2.97 Million - $3.41 Million	15,000 New	15,000 $3.41 Million
Q1 2019 Apr 11, 2019	SELL	$123.7 - $156.3 $1.36 Million - $1.72 Million	-11,000 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$120.82 - $174.09 $1.33 Million - $1.91 Million	11,000 New	11,000 $1.39 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.